DGX
HealthcareQuest Diagnostics Incorporated
$173.49
$-0.30 (-0.17%)
Jan 5, 2026
Price History (1Y)
Analysis
Quest Diagnostics Incorporated is a leading healthcare company in the diagnostics and research sector. With a market capitalization of $19.40B, revenue of $10.85B, and approximately 45,000 employees, the company operates at a substantial scale. The financial health of Quest Diagnostics Incorporated indicates moderate profitability, with gross margins of 33.4%, operating margins of 14.9%, and profit margins of 8.9%. The company's returns on equity (ROE) and assets (ROA) are 14.4% and 6.1%, respectively. The balance sheet shows a debt-to-equity ratio of 86.52, indicating significant indebtedness, while cash reserves stand at $435.00M. Valuation metrics for Quest Diagnostics Incorporated reveal a price-to-earnings (P/E) ratio of 20.41 and forward P/E of 16.72, suggesting moderate valuation. Revenue growth has been 13.2% year-over-year (YoY), while earnings growth has been 8.5% YoY. The company's dividend yield is 184.0%, with a payout ratio of 37.0%.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About Quest Diagnostics Incorporated
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, emerging retail healthcare providers, pharmaceutical companies and insurers, commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. In addition, the company offers risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
Visit website →Key Statistics
- Market Cap
- $19.40B
- P/E Ratio
- 20.41
- 52-Week High
- $197.55
- 52-Week Low
- $148.70
- Avg Volume
- 1.06M
- Beta
- 0.64
- Dividend Yield
- 184.00%
Company Info
- Industry
- Diagnostics & Research
- Exchange
- NYQ
- Country
- United States
- Employees
- 45,000